PAGIBAXIMAB
UNII 23KB56UHN9

Substance Identification & Data

This profile provides standardized clinical and technical data for Pagibaximab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 23KB56UHN9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 595566-61-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

23KB56UHN9

CAS Registry Number

595566-61-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PAGIBAXIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C188495

National Cancer Institute reference terminology for clinical and research data.

INN ID

8643

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

QQ-73

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pagibaximab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PAGIBAXIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI (STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID) (HUMAN MOUSE MONOCLONAL HU96 110 HEAVY CHAIN), DISULFIDE WITH HUMAN MOUSE MONOCLONAL HU96 110 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI (STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID) (HUMAN MOUSE MONOCLONAL HU96 110 HEAVY CHAIN), DISULPHIDE WITH HUMAN MOUSE MONOCLONAL HU96 110 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID)(HUMAN-MOUSE MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID)(HUMAN-MOUSE MONOCLONAL HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL .KAPPA.-CHAIN, DIMER

PAGIBAXIMAB [INN]

PAGIBAXIMAB [USAN]